Immune approaches in tuberculosis therapy: a brief overview. - Wikidata - wikimedia - TriplyDB

Immune approaches in tuberculosis therapy: a brief overview.

Immune approaches in tuberculosis therapy: a brief overview.

http://www.wikidata.org/entity/Q37991393

about

Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7)Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7)Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection.An overview of tuberculosis plant-derived vaccines.Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L.Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis.Adjunct immune therapy of first-diagnosed TB, relapsed TB, treatment-failed TB, multidrug-resistant TB and TB/HIV.Immunomodulation and infection: back to the future.

P2860

Q28293125-3226BCE1-D692-4860-B5FD-2CB122056825 Q28299689-E0776A97-FF12-4376-B405-51AA76B976E6 Q37071295-E2099B83-9E5D-461E-8650-C0FC82E76206 Q38356275-9F1D9A5B-3E51-49C6-A486-1103334D7145 Q40227841-AD174EE6-0ADD-4A9D-B77C-6C28F5D6FB96 Q40442949-A98AD58A-3537-4AF4-9D91-0D1C218F68A1 Q44579437-98DABFD2-C358-4FC2-B6F3-DDEB6871C40A Q51622254-03EDB442-EC85-4D43-8EEB-DAE977D05BA0

P2860

Immune approaches in tuberculosis therapy: a brief overview.

http://www.wikidata.org/entity/Q37991393

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Immune approaches in tuberculosis therapy: a brief overview.

@en

Immune approaches in tuberculosis therapy: a brief overview.

@nl

type

label

Immune approaches in tuberculosis therapy: a brief overview.

@en

Immune approaches in tuberculosis therapy: a brief overview.

@nl

prefLabel

Immune approaches in tuberculosis therapy: a brief overview.

@en

Immune approaches in tuberculosis therapy: a brief overview.

@nl

P1433

Q37991393-7BA0975E-D698-45CF-B1AC-A278E086E256

P1476

Q37991393-BECBBA05-AB13-47C7-ACAD-1EC6010D24A9

P2093

Q37991393-076B5060-1488-4531-985E-C1921BB2B158

Q37991393-49F06781-1105-4CB7-9DD4-CB55721834A6

Q37991393-4B0F45A7-5587-4177-A5FC-8C66CAA0FD05

Q37991393-79ED4BB5-CC44-4B15-AB60-1FB02C2C7765

Q37991393-B74BA1BE-173B-45EB-900B-1D3B518B2A06

Q37991393-BF995F00-A95A-4920-B9AC-77F879388272

Q37991393-C82B59F8-DF03-4DEA-8F48-4F29A377E9D5

Q37991393-E494321D-01A4-4AF9-A433-11E34F9E2677

P2860

Q37991393-3245F4BC-45C4-49D0-A0EB-3C03CB510456

Q37991393-3FB25EFB-1FDF-4F9E-A11B-F5591AFED3D3

Q37991393-4AF1CD5C-834A-4E08-838F-56D4FF1A8DE4

Q37991393-54A8DE59-5001-48FB-9B5E-8A69813ABF9A

Q37991393-5CBB1762-D434-48C7-AA15-81A078418818

Q37991393-684F8B23-6A1E-492C-AFCE-59F296C9F86E

Q37991393-6CD8A2F8-B85B-4A88-B95C-B2222ED2077F

Q37991393-893951E7-EA64-49DE-B2DA-4AEAEA834D16

Q37991393-934C714B-C51C-4CFA-8AF6-4FD90AC364AE

Q37991393-9EC1ACB5-D1D7-47BC-B88D-07A0BE6DFB56

P304

Q37991393-6F928F5B-235D-438A-9894-A66AD83F0FBE

P31

Q37991393-82DCD0B1-CB84-43FC-9A74-D1D248D3ECAD

P356

Q37991393-DD52EA3B-DCB5-48D0-BD96-E314F61CD8A4

P433

Q37991393-86281630-4D33-4A10-B1D4-516FDC31062D

P478

Q37991393-88AAAEF8-3DA5-49D6-946A-F1BB2E910EFF

P577

Q37991393-D2385C2C-09EF-4EF7-BCB0-AB64F8FC7C98

P5875

Q37991393-84559F66-0FAE-4E6B-8083-CC0B4AE2EDCF

P698

Q37991393-3D22FDD5-AA25-4E89-9BFE-E5CB8C1A94B5

P921

Q37991393-4A901983-CAD2-49B5-A361-7841B9C137FA

P356

P1433

Expert Review of Anti-infective Therapy

P1476

Immune approaches in tuberculosis therapy: a brief overview.

@en

P2093

Aldar S Bourinbaiar

http://www.w3.org/2001/XMLSchema#string

Dmitry A Butov

http://www.w3.org/2001/XMLSchema#string

Galyna A Kutsyna

http://www.w3.org/2001/XMLSchema#string

Marina V Mezentseva

http://www.w3.org/2001/XMLSchema#string

Peter S Nyasulu

http://www.w3.org/2001/XMLSchema#string

Vichai Jirathitikal

http://www.w3.org/2001/XMLSchema#string

Vladimir V Mishchenko

http://www.w3.org/2001/XMLSchema#string

Yuri V Efremenko

http://www.w3.org/2001/XMLSchema#string

P2860

Phase IIb randomized trial of adjunct immunotherapy in patients with first-diagnosed tuberculosis, relapsed and multi-drug-resistant (MDR) TB

Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis

Treatment of cavitary and infiltrating pulmonary tuberculosis with and without the immunomodulator Dzherelo

Mycobacterium tuberculosis infection induces non-apoptotic cell death of human dendritic cells.

Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products.

Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis.

Synthetic and natural immunomodulators acting as interferon inducers.

Infections and autoimmunity--friends or foes?

Tuberculin immunotherapy: its history and lessons to be learned.

Advances in immunotherapy for tuberculosis treatment.

P304

381-389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERI.12.1

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221684234

http://www.w3.org/2001/XMLSchema#string

P698

22397570

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde